M08.069, Unspecified juvenile rheumatoid arthritis, unspecified kneeICD-10-CM
No Prior Auth Required
Covered without prior authorization by at least one policy, though another does not cover it (medium confidence)
A59434, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J5
A52423, Billing and Coding: Infliximab and biosimilars
J6
NGS-J6-L33394, Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
J6
A58893, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J6
A57765, Billing and Coding: Major Joint Replacement (Hip and Knee)
J9
FIRST_COAST-L33618, Major Joint Replacement (Hip and Knee)
J9
FIRST_COAST-L34021, Sedimentation Rate, Erythrocyte
J9
A57657, Billing and Coding: Sedimentation Rate, Erythrocyte
J9
A59764, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J9
NGS-JK-L33394, Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
JK
A59766, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
JL
A59374, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
A58865, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
Ask Backwork about documentation requirements, denial risks, or coverage in your state.